Login / Signup

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.

Takuya KawaharaTomohiro ShinozakiYutaka Matsuyama
Published in: BMC medical research methodology (2020)
The proposed estimator is useful for estimation of risk if censoring is affected by time-varying risk factors.
Keyphrases
  • risk factors
  • coronary artery disease
  • clinical trial
  • coronary artery
  • heart failure
  • phase iii
  • phase ii
  • atrial fibrillation